Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-035615

Chief Executive Officer sold 13,000 shares at an average $95.35 ($1,239,608)

  • Chief Executive Officer acquired 13,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2018-06-01 Option exercise +12,892 $0.47 $6,027 12,892 D
Schenkein David P Chief Executive Officer 2018-06-01 Option exercise +108 $2.34 $253 13,000 D
Schenkein David P Chief Executive Officer 2018-06-01 Sale −1,510 $94.37 $142,499 11,490 D
Schenkein David P Chief Executive Officer 2018-06-01 Sale −8,200 $95.11 $779,902 3,290 D
Schenkein David P Chief Executive Officer 2018-06-01 Sale −3,190 $96.40 $307,516 100 D
Schenkein David P Chief Executive Officer 2018-06-01 Sale −100 $96.91 $9,691 0 D
Derivatives
Schenkein David P Chief Executive Officer 2018-06-01 Option exercise · Stock option (right to buy) −12,892 0 D
Schenkein David P Chief Executive Officer 2018-06-01 Option exercise · Stock option (right to buy) −108 72,619 D
Open-market sales · 13,000 sh · avg $95.35 · $1,239,608
Loading xslF345X03/doc4.xml…